T22‐GFP‐H6‐FdU‐induced reduction in tumor re‐initiation capacity and blockade of tumor emboli intravasation in the CXCR4+ patient‐derived M5 model T22‐GFP‐H6‐FdU‐induced.

Slides:



Advertisements
Similar presentations
Role of TNF in fracture healing in vivo Addition of rhTNF at the fracture site on days 0 and 1 led to augmented healing, indicated by increased % callus.
Advertisements

Dual anti‐Ang‐2 and anti‐VEGF therapy acts synergistic on vascular normalization and macrophage infiltration in experimental GBM Dual anti‐Ang‐2 and anti‐VEGF.
Neuro‐inflammatory cytokines, brain microglial activation, and working memory deficits are normalized using LV.IDS.ApoEII, but not LV.IDS in MPS II mice.
The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.
PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.
Klotho reduction increases the expression of cytokine response factors in the CP. (A–C) ICAM1 (A and B) and IRF7 (C) immunoreactivity in the CP of 19-
[68Ga]Pentixafor PET imaging of MM xenografts Real‐time PCR analysis of cxcr4 transcript expression levels in HeLa (negative control) and in MM cell lines.
AAV8‐hAAT‐FGF21 treatment improves liver fibrosis
BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.
Dual LGR5 and KI67 knock‐in PDOs enable separation of quiescent and cycling LGR5+ CRC cells Dual LGR5 and KI67 knock‐in PDOs enable separation of quiescent.
VAP‐A is recruited to interorganelle contact sites together with MOSPD2 VAP‐A is recruited to interorganelle contact sites together with MOSPD2 AHeLa cells.
Metabolic profile of Tfe3 KO mice
Both haematopoietic and non‐haematopoietic compartments are involved in myocarditis development.A.Kaplan‐Meier survival curves showing survival of bone.
MET‐expressing GSCs are selected by irradiation
TGF‐β1 and Sema3A are downregulated in vivo by increasing VEGF doses Muscles were harvested 7 days after implantation of V Low, V Med, and V High clones.
Expression of FUT9 supports tumor development
ADAM8 promotes cancer cell adhesion to endothelial cells via β1‐integrin activation ABlood was drawn using the submandibular collection method from 4 mice/group.
Stat3 promotes lung fibrosis and collagen synthesis independent of Smad3.A.Masson's trichrome stained sections of lung from gp130wt (wt), Smad3−/− (Smad3−/−),
TFE3 prevents diet‐induced obesity and metabolic syndrome
SPP1 and TNC are induced by active JNK and promote lung metastasis
Selective biodistribution and receptor‐dependent uptake of T22‐GFP‐H6‐FdU in CXCR4+ cells in vivo Selective biodistribution and receptor‐dependent uptake.
JNK signaling mediates mammary tumor growth and metastasis to lungs
Negligible T22‐GFP‐H6‐FdU biodistribution or toxicity on non‐tumor tissues Negligible T22‐GFP‐H6‐FdU biodistribution or toxicity on non‐tumor tissues AUndetectable.
Fig. 4. Antitumor efficacy of ERY974 against various cancer types.
SPP1 and TNC promote chemoresistance
T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells in tumor tissue leading to reduced spheroid formation capacity T22‐GFP‐H6‐FdU‐induced.
SKAP55‐deficient mice enhance DC‐based vaccine for prevention of tumors in vivo AWT and SKAP55 KO C57BL/6 mice were s.c. immunized on day −14 and day −7.
Combined BET/MEK inhibition offsets therapy resistance
T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived model in a CXCR4‐dependent manner T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived.
Combination of OTX‐015 and PD does not induce overt toxicity
Endogenous MOSPD2 is recruited to interorganelle contact sites by FFAT‐containing proteins Endogenous MOSPD2 is recruited to interorganelle contact sites.
BETi potentiate the efficacy of MEKi in NRAS‐mutant melanoma
Inhibition of JNK signaling sensitizes mammary tumors and metastases to chemotherapy Inhibition of JNK signaling sensitizes mammary tumors and metastases.
Intra‐eWAT administration of FGF21 vectors in ob/ob mice
Nec‐1 inhibits the phosphorylation and aggregation of tau
Rescuing mGPDH deficiency improves skeletal muscle regeneration during obesity and diabetes Rescuing mGPDH deficiency improves skeletal muscle regeneration.
The psoriatic phenotype of DKO
Impaired ECM protein synthesis in infarcted area of S100a4cre+/− × Fstl1flox/flox mice Impaired ECM protein synthesis in infarcted area of S100a4cre+/−
Association of AIM2, RIG‐I and NLRP3 inflammasomes with better survival in NPC patients.A.Overexpression of ASC, caspase‐1 and IL‐1β proteins as well as.
Isabelle Plaisance et al. BTS 2016;j.jacbts
Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+ tumors Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+
SPP1 and TNC are induced by chemotherapy via JNK signaling
IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice ARepresentative.
Assessment of intracerebral micro‐hemorrhages in APP23‐transgenic mice, dosed orally with CNP520 at 30 mg/kg for 3 months Assessment of intracerebral micro‐hemorrhages.
BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.
Increased LIMD1 expression in hypoxia inhibits tumour growth and vascularisation Increased LIMD1 expression in hypoxia inhibits tumour growth and vascularisation.
Effect of antiangiogenic TKIs and rMVA–CEA–TRICOM vaccine on tumor compactness, tight junctions, and intratumoral pressure in the MC38-CEA model. Effect.
Assessment of proliferation status of PDGFRα+ cells in developing mouse lungs Assessment of proliferation status of PDGFRα+ cells in developing mouse lungs.
P2X4R blockade increases autoimmune inflammation
Prazosin inhibits GIC survival
Treatment with AZD5363 reduces the proportion of proliferating vascular endothelial cells and following RT, the influx of CD11b+ bone marrow‐derived cells.
ALK5 inhibition induces ubiquitin‐mediated degradation of Smad4 in CD8+ T cells in melanoma‐bearing mice Source data is available for this figure in the.
T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells in tumor tissue T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells.
Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts.
Sox2 is essential for SLG regeneration following radiation injury
Effect of D‐Asp treatment on myelination and remyelination in cerebellar organotypic slices Effect of D‐Asp treatment on myelination and remyelination.
P2X4R blockade increases pro‐inflammatory gene expression after EAE
FGFR1 and TGFβ signaling activity in smooth muscle cells in a mouse atherosclerosis model FGFR1 and TGFβ signaling activity in smooth muscle cells in a.
Tangle formation and downregulation of miR‐132‐3p in LOAD A‐G
ADAM8 is induced by hypoxia and promotes angiogenesis ASixteen h after plating, cells were cultured under normoxic (−) or hypoxic (+, 1% O2) conditions.
Bevacizumab therapy leads to reduced vessel density and increased Ang‐2 expression Bevacizumab therapy leads to reduced vessel density and increased Ang‐2.
Absence of miR‐21 in macrophages promotes foam cell formation
Bazedoxifene suppresses IL11‐mediated STAT3 signaling activity in human cancer cell lines and patient‐derived colon cancer primary cultures and organoids.
SEMA3C regulates prostate cancer cell growth
Niacin suppresses pro‐inflammatory cytokine expression in macrophages in DSS‐induced colitis in mice Niacin suppresses pro‐inflammatory cytokine expression.
Expression of p110γ isoform in macrophages promotes tumor growth and angiogenesis. Expression of p110γ isoform in macrophages promotes tumor growth and.
In vivo thrombosis of tumor vasculature.
Anti-Flk-1 mAb inhibits vascularization of Matrigel plugs.
Representative macrophage staining images only from the knee joints of CAIA mice injected s.c. with GalNAc–MASP-3–siRNA duplex 2 or GalNAc–luciferase–siRNA.
Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.
Presentation transcript:

T22‐GFP‐H6‐FdU‐induced reduction in tumor re‐initiation capacity and blockade of tumor emboli intravasation in the CXCR4+ patient‐derived M5 model T22‐GFP‐H6‐FdU‐induced reduction in tumor re‐initiation capacity and blockade of tumor emboli intravasation in the CXCR4+ patient‐derived M5 model A, BReduction in the number of formed spheroids (white arrows, optical microscope) generated by 1 × 106 disaggregated cells (cultured in stem cell‐conditioned media and low‐adhesion plates) obtained from CXCR4+ M5 subcutaneous tumors, 24 h after 100 μg T22‐GFP‐H6‐FdU intravenous doses, for 2 consecutive days, as compared to Buffer‐treated or free oligo‐FdU‐treated mice (mean ± s.e.m., N = 8; 2 mice/group; 4 plates/mouse). Scale bar, 100 μm. Comparison of spheroid formation between groups: (B: Buffer; F: free oligo‐FdU; T‐F: T22‐GFP‐H6‐FdU). P‐values for statistical differences: T‐F vs. B, **P = 0.001 (green line, Panel B); F vs. B, *P = 0.012 (red line); T‐F vs. F, **P = 0.001 (black line). Mann–Whitney U‐test.C, DReduction in tumor re‐initiation capacity after subcutaneous inoculation of 5 × 106 cells in NSG mice (N = 4 tumors/group) derived from disaggregated tumor cells obtained from SC tumors 10 days after administration of 100 μg T22‐GFP‐H6‐FdU intravenous doses, for 2 consecutive days, as compared to free oligo‐FdU‐treated or Buffer‐treated mice. Recording of the number and size of positive tumors (black arrows, N = 4; 2 mice/group, 2 injection points/mouse).E–G(E) Representative images of tumor emboli intravasation determined by microscopic analyses of H&E‐stained tumor sections (N = 5/group). (F) T22‐GFP‐H6‐FdU‐induced reduction in the number of intravasated tumor emboli (black arrows) in peri‐tumoral vessels of the M5‐orthotopic primary tumor (E: optical images; F: emboli number quantitation) and reduction in CXCR4 expression in these emboli (G), treated 7 days after tumor cell implantation with 100 μg T22‐GFP‐H6‐FdU intravenous doses, for 2 consecutive days, as compared to Buffer‐treated or free oligo‐FdU‐treated mice. Tumor emboli counting in 10 high‐power field at 200× magnification in H&E‐stained sections from each tumor (mean ± s.e.m., N = 5/group). Comparison of tumor emboli number between groups: (B: Buffer; F: free oligo‐FdU; T‐F: T22‐GFP‐H6‐FdU). P‐values for statistical differences: T‐F vs. B, *P = 0.038 (green line), T‐F vs. F, *P = 0.016 (black line). Scale bar, 100 μm. (G) CXCR4 expression per tumor emboli determined by using anti‐CXCR4 IHC and calculating H‐score (multiplying percent of CXCR4+ cells out of total cell number in the emboli area by their staining intensity, scoring each from 0 to 3 (where 3 is the maximal intensity) per tumor emboli area (mean ± s.e.m., N = 5 mice/group). Comparison of CXCR4 H‐score between groups: (B: Buffer; T‐F: T22‐GFP‐H6‐FdU). P‐values for statistical differences: T‐F vs. B at *P = 0.027 (green line). Mann–Whitney U‐test. María Virtudes Céspedes et al. EMBO Mol Med. 2018;emmm.201708772 © as stated in the article, figure or figure legend